MedPath

Hydralazine Hydrochloride

HYDRALAZINE HYDROCHLORIDE TABLETS, USP

Approved
Approval ID

2c65df39-26d8-4428-8306-d43cbfcaf162

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 3, 2015

Manufacturers
FDA

State of Florida DOH Central Pharmacy

DUNS: 829348114

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Hydralazine Hydrochloride

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code53808-1062
Application NumberANDA040901
Product Classification
M
Marketing Category
C73584
G
Generic Name
Hydralazine Hydrochloride
Product Specifications
Route of AdministrationORAL
Effective DateJanuary 3, 2015
FDA Product Classification

INGREDIENTS (6)

ANHYDROUS LACTOSEInactive
Code: 3SY5LH9PMK
Classification: IACT
STEARIC ACIDInactive
Code: 4ELV7Z65AP
Classification: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT
HYDRALAZINE HYDROCHLORIDEActive
Quantity: 50 mg in 1 1
Code: FD171B778Y
Classification: ACTIB
SODIUM STARCH GLYCOLATE TYPE A POTATOInactive
Code: 5856J3G2A2
Classification: IACT
FD&C YELLOW NO. 6Inactive
Code: H77VEI93A8
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Hydralazine Hydrochloride - FDA Drug Approval Details